A detailed history of Jpmorgan Chase & CO transactions in Orthofix Medical Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 14,531 shares of OFIX stock, worth $251,822. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,531
Previous 46,397 68.68%
Holding current value
$251,822
Previous $673,000 71.47%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$12.38 - $15.37 $394,501 - $489,780
-31,866 Reduced 68.68%
14,531 $192,000
Q1 2024

May 10, 2024

BUY
$12.67 - $14.62 $123,671 - $142,705
9,761 Added 26.64%
46,397 $673,000
Q4 2023

Feb 12, 2024

SELL
$9.69 - $14.21 $3,876 - $5,684
-400 Reduced 1.08%
36,636 $493,000
Q3 2023

Nov 14, 2023

SELL
$12.4 - $21.36 $54,150 - $93,279
-4,367 Reduced 10.55%
37,036 $476,000
Q2 2023

Aug 11, 2023

SELL
$16.58 - $20.31 $6.22 Million - $7.62 Million
-374,964 Reduced 90.06%
41,403 $747,000
Q1 2023

May 18, 2023

BUY
$15.45 - $22.76 $405,794 - $597,791
26,265 Added 6.73%
416,367 $6.97 Million
Q1 2023

May 11, 2023

BUY
$15.45 - $22.76 $3.53 Million - $5.2 Million
228,269 Added 141.05%
390,102 $6.53 Million
Q4 2022

Feb 13, 2023

SELL
$14.33 - $20.87 $69,543 - $101,282
-4,853 Reduced 2.91%
161,833 $3.32 Million
Q3 2022

Nov 14, 2022

SELL
$19.11 - $25.93 $81,504 - $110,591
-4,265 Reduced 2.49%
166,686 $3.19 Million
Q2 2022

Aug 11, 2022

SELL
$23.54 - $34.89 $37,687 - $55,858
-1,601 Reduced 0.93%
170,951 $4.03 Million
Q1 2022

May 11, 2022

SELL
$29.75 - $35.83 $113,407 - $136,583
-3,812 Reduced 2.16%
172,552 $5.64 Million
Q4 2021

Feb 10, 2022

SELL
$28.91 - $39.31 $554,378 - $753,808
-19,176 Reduced 9.81%
176,364 $5.48 Million
Q3 2021

Nov 12, 2021

BUY
$37.34 - $42.86 $7.3 Million - $8.38 Million
195,540 New
195,540 $7.45 Million

Others Institutions Holding OFIX

About Orthofix Medical Inc.


  • Ticker OFIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 20,007,100
  • Market Cap $347M
  • Description
  • Orthofix Medical Inc. operates as a medical device and biologics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulator...
More about OFIX
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.